Agilent

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agilent and other ETFs, options, and stocks.

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. 

CEO
Padraig Mcdonnell
CEOPadraig Mcdonnell
Employees
18,100
Employees18,100
Headquarters
Santa Clara, California
HeadquartersSanta Clara, California
Founded
1999
Founded1999
Employees
18,100
Employees18,100

A Key Statistics

Market cap
35.28B
Market cap35.28B
Price-Earnings ratio
27.28
Price-Earnings ratio27.28
Dividend yield
0.80%
Dividend yield0.80%
Average volume
2.42M
Average volume2.42M
High today
High today
Low today
Low today
Open price
$125.40
Open price$125.40
Volume
0.00
Volume0.00
52 Week high
$160.27
52 Week high$160.27
52 Week low
$96.43
52 Week low$96.43

Stock Snapshot

As of today, Agilent(A) shares are valued at $121.00. The company's market cap stands at 35.28B, with a P/E ratio of 27.28 and a dividend yield of 80.1%.

During the trading day, Agilent(A) stock saw an opening price of $125.40, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 2.42M.

Over the past 52 weeks, Agilent(A) stock has traded between a high of $160.27 and a low of $96.43.

Over the past 52 weeks, Agilent(A) stock has traded between a high of $160.27 and a low of $96.43.

A News

TipRanks 2h
Agilent price target lowered to $150 from $165 at Barclays

Barclays lowered the firm’s price target on Agilent (A) to $150 from $165 and keeps an Overweight rating on the shares. The firm updated the company’s model pos...

TipRanks 5h
Weather-Driven Miss Masks Underlying Strength at Agilent, Creating a Buy Opportunity

Analyst Daniel Brennan from TD Cowen maintained a Buy rating on Agilent and decreased the price target to $157.00 from $170.00. Daniel Brennan has given his Bu...

The Motley Fool 13h
Agilent Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. Wednesday, Feb. 25, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Padraig McDonnell Chief Financial Officer —...

Agilent Q1 2026 Earnings Call Transcript

Analyst ratings

78%

of 23 ratings
Buy
78.3%
Hold
21.7%
Sell
0%

More A News

Nasdaq 15h
Agilent Technologies Reports Drop In Q1 Profit

(RTTNews) - Agilent Technologies (A) reported earnings for first quarter that Drops, from the same period last year The company's earnings totaled $305 million...

Agilent Technologies Reports Drop In Q1 Profit
TipRanks 15h
Agilent reports Q1 EPS $1.36, consensus $1.37

Reports Q1 revenue $1.80B, consensus $1.81B. “It was a solid start to the year with the Agilent (A) team executing well in a healthy – albeit dynamic – market e...

Nasdaq 1d
Agilent Technologies Q1 26 Earnings Conference Call At 4:30 PM ET

(RTTNews) - Agilent Technologies(A) will host a conference call at 4:30 PM ET on Feb. 25, 2026, to discuss Q1 26 earnings results. To access the live webcast,...

Agilent Technologies Q1 26 Earnings Conference Call At 4:30 PM ET
Simply Wall St 2d
Assessing Agilent Technologies Valuation As Earnings Approach And New FDA Diagnostic Approval Draws Interest

Investor focus on Agilent Technologies (A) is picking up as the life sciences tools company heads into its upcoming earnings report, with attention also on fres...

Assessing Agilent Technologies Valuation As Earnings Approach And New FDA Diagnostic Approval Draws Interest
Simply Wall St 3d
FDA Approval Deepens Agilent Role In KEYTRUDA Ovarian Cancer Testing

Agilent Technologies (NYSE:A) received FDA approval for its PD-L1 IHC 22C3 pharmDx test as the only FDA approved companion diagnostic for certain ovarian, fallo...

FDA Approval Deepens Agilent Role In KEYTRUDA Ovarian Cancer Testing
Nasdaq 6d
Friday Sector Laggards: Healthcare, Energy

Looking at the sectors faring worst as of midday Friday, shares of Healthcare companies are underperforming other sectors, not showing much of a gain. Within th...

Friday Sector Laggards: Healthcare, Energy

People also own

Based on the portfolios of people who own A. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.